The University of Health Sciences and Pharmacy in St Louis Board of Trustees has named David D Allen, RP., PhD, FASHP, FNAP, FAPhA, as its new president effective 1 July 2021, it was reported on Wednesday.
Allen has served as dean of the School of Pharmacy, professor of biomolecular sciences and executive director of and research professor in the Research Institute of Pharmaceutical Sciences at the University of Mississippi. He was dean of pharmacy at the Northeast Ohio Medical University College of Pharmacy, formerly Northeastern Ohio Universities College of Pharmacy, in Rootstown, Ohio, and associate dean of curricular affairs at the Texas Tech University Health Sciences Center School of Pharmacy in Amarillo, Texas. He was also a professor of physiology and pharmacology in NEOMED's College of Medicine while he was the dean of pharmacy.
Allen is to succeed John A Pieper, PharmD, FCCP, FAPhA, FFIP.
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business